Internal Medicine, Nephrology · Upland, CA
NPI
1124333141
Since 2010
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1317 W Foothill Blvd Ste 148
Upland, CA, 91786
Phone (909) 981-5882
Groups this clinician bills Medicare through
Medicare paid, 2024
$254K
3,487 services
Medicare patients, 2024
398
Average age 73
Drug cost, 2024
$1.4M
1,890 prescriptions
Company payments, 2025
$751
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saman Sarani was code 99233 (hospital e&m - subsequent), 812 times for 200 patients. In total Saman Sarani billed 3,487 services in 20 codes, and Medicare paid $254K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 812 | 200 | $85.96 | $70K |
| 99458 E&M - Miscellaneous | Office | 406 | 32 | $28.72 | $12K |
| 90960 ESRD Related Services (not dialysis) | Office | 339 | 58 | $258.80 | $88K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 262 | 23 | $34.74 | $9,103 |
| 99214 Office E&M - Established | Office | 230 | 108 | $66.09 | $15K |
| 99457 E&M - Miscellaneous | Office | 225 | 46 | $35.53 | $7,993 |
| 99454 E&M - Miscellaneous | Office | 194 | 30 | $35.22 | $6,833 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 154 | 24 | $34.38 | $5,295 |
| 99223 Hospital E&M - Initial | Facility | 124 | 116 | $125.75 | $16K |
| 99205 Office E&M - New | Office | 27 | 27 | $142.18 | $3,839 |
| 90961 ESRD Related Services (not dialysis) | Office | 24 | 15 | $220.16 | $5,284 |
| 99453 E&M - Miscellaneous | Office | 14 | 14 | $15.48 | $217 |
By year: 2022 $217K for 2,134 services; 2023 $241K for 2,786 services; 2024 $254K for 3,487 services.
Medicare prescription drug claims, 2024
In 2024, the drug Saman Sarani prescribed most often to Medicare patients was Losartan Potassium, with 171 prescriptions and refills. In total Saman Sarani wrote 1,890 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 171 | 425 | 54 | $1,570 |
| Hydralazine Hcl Generic | 168 | 434 | 68 | $2,668 |
| Farxiga Dapagliflozin Propanediol | 152 | 215 | 32 | $114K |
| Veltassa Patiromer Calcium Sorbitex | 147 | 171 | 31 | $164K |
| Amlodipine Besylate Generic | 100 | 250 | 35 | $533 |
| Furosemide Generic | 89 | 231 | 34 | $548 |
| Prosol Parenteral Amino Acid 20% No.1 | 80 | 80 | Under 11 | $11K |
| Kerendia Finerenone | 64 | 100 | 17 | $62K |
| Clinolipid Fat Emulsion/Olive/Soy/Phospho | 52 | 52 | Under 11 | $16K |
| Carvedilol Generic | 45 | 113 | 15 | $393 |
| Potassium Chloride Generic | 38 | 108 | 11 | $633 |
| Allopurinol Generic | 35 | 101 | 13 | $368 |
| Lokelma Sodium Zirconium Cyclosilicate | 33 | 41 | Under 11 | $33K |
| Chlorthalidone Generic | 32 | 90 | 11 | $721 |
| Sevelamer Carbonate Generic | 32 | 76 | 15 | $5,516 |
Brand drugs: 643 claims; generic drugs: 1,219 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saman Sarani $751 ($751 in general payments such as food, travel and fees) from 12 companies. The largest payer was Travere Therapeutics, Inc. with $186.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 9 | $186 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $146 |
| Amgen Inc. AMGN | 1 | $101 |
| Akebia Therapeutics Inc AKBA | 4 | $88.56 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $49.9 |
| Calliditas Therapeutics US Inc. | 1 | $37.87 |
| Ardelyx, Inc. ARDX | 2 | $35.13 |
| GlaxoSmithKline, LLC. GSK | 1 | $26.73 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $24.64 |
| Aurinia Pharma U.S., Inc. AUPH | 1 | $18.71 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.